Chelsea Therapeutics International's P2P Acquisition

Chelsea Therapeutics International raised a round of funding on June 23, 2014. Investors include H. Lundbeck.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human diseases that address imp…

Articles about Chelsea Therapeutics International's P2P Acquisition: